Fresenius Medical Care AG (FRA:FMEA)

Market Cap	13.05B
Revenue (ttm)	19.49B
Net Income (ttm)	618.18M
Shares Out	n/a
EPS (ttm)	2.11
PE Ratio	21.11
Forward PE	11.82
Dividend	0.51 (2.28%)
Ex-Dividend Date	May 23, 2025

Volume	30
Average Volume	87
Open	22.20
Previous Close	22.00
Day's Range	22.20 - 22.20
52-Week Range	16.40 - 27.20
Beta	n/a
RSI	38.48
Earnings Date	Aug 5, 2025

About MorphoSys AG

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospital...

• Industry: Miscellaneous Health And Allied Services, Not Elsewhere Classified
• Founded: 1996
• Employees: 111,513
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: FMEA

Financial Performance

In 2024, Fresenius Medical Care AG's revenue was 19.34 billion, a decrease of -0.61% compared to the previous year's 19.45 billion. Earnings were 537.91 million, an increase of 7.80%.